Literature DB >> 15024191

Inflammatory changes in vitiligo: stage I and II depigmentation.

Khalifa E Sharquie1, Shihab H Mehenna, Abbas A Naji, Hani Al-Azzawi.   

Abstract

Frequent failure of early studies to demonstrate inflammatory changes in vitiligo led many investigators to consider the disease as noninflammatory. However, others found an inflammatory element in vitiliginous lesions. In this study we tried to verify that assumption. Twenty-five patients (10 males and 15 females) with common vitiligo and 11 normal healthy individuals were included. Histopathologic studies were carried out using epon-embedded sections stained with modified toluidine blue stain. Comparisons of the results of histopathologic examination of the stained specimens of vitiliginous lesions (both stage I and II), marginal areas, and uninvolved normal skin of vitiligo patients with normal healthy control were performed. Focal spongiosis was observed in 48% of the specimens of vitiligo patients and largely limited to the marginal areas and stage I vitiligo lesions. Epidermal mononuclear cell infiltration was seen in 80% of both the marginal areas and stage I vitiligo specimens. The number of these cells was significantly higher than that in stage II lesions and uninvolved skin. Many of the epidermotropic lymphocytes were grouped together, forming clusters resembling Pautrier microabscesses. The extent of epidermal mononuclear cell invasion did not always parallel the density of the subjacent dermal infiltrate. Vitiligo is an inflammatory disease, and the epidermal lymphocytic infiltration is most likely the primary immunologic event.

Entities:  

Mesh:

Year:  2004        PMID: 15024191     DOI: 10.1097/00000372-200404000-00004

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  8 in total

Review 1.  The link between cutaneous inflammation and cognitive impairment.

Authors:  S Wen; P M Elias; J S Wakefield; T M Mauro; M-Q Man
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-07-02       Impact factor: 9.228

2.  Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference.

Authors:  K Ezzedine; H W Lim; T Suzuki; I Katayama; I Hamzavi; C C E Lan; B K Goh; T Anbar; C Silva de Castro; A Y Lee; D Parsad; N van Geel; I C Le Poole; N Oiso; L Benzekri; R Spritz; Y Gauthier; S K Hann; M Picardo; A Taieb
Journal:  Pigment Cell Melanoma Res       Date:  2012-05       Impact factor: 4.693

Review 3.  Stability in Vitiligo: Is there a Perfect Way to Predict it?

Authors:  Kanika Sahni; Davinder Parsad
Journal:  J Cutan Aesthet Surg       Date:  2013-04

4.  Association between Vitiligo and Thyroid Autoimmunity.

Authors:  Emina Kasumagic-Halilovic; Asja Prohic; Begler Begovic; Nermina Ovcina-Kurtovic
Journal:  J Thyroid Res       Date:  2011-05-04

5.  Hypothesis: zinc can be effective in treatment of vitiligo.

Authors:  Nooshin Bagherani; Reza Yaghoobi; Mohammad Omidian
Journal:  Indian J Dermatol       Date:  2011 Sep-Oct       Impact factor: 1.494

6.  Aspirin in dermatology: Revisited.

Authors:  Aditya Kumar Bubna
Journal:  Indian Dermatol Online J       Date:  2015 Nov-Dec

7.  Psoriasis and vitiligo are close relatives.

Authors:  Khalifa E Sharquie; Husam Ali Salman; Aseel K Yaseen
Journal:  Clin Cosmet Investig Dermatol       Date:  2017-08-29

8.  Segmental and generalized vitiligo: both forms demonstrate inflammatory histopathological features and clinical mosaicism.

Authors:  Venkat Ratnam Attili; Sasi Kiran Attili
Journal:  Indian J Dermatol       Date:  2013-11       Impact factor: 1.494

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.